<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://www.pharmawire.org/latest-news/novo-backed-windward-bio-targets-1bn-valuation-in-us-ipo</loc><news:news><news:publication><news:name>PharmaWire.org</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T08:09:38.000Z</news:publication_date><news:title>Novo-backed Windward Bio targets $1bn valuation in US IPO</news:title></news:news></url>
<url><loc>https://www.pharmawire.org/latest-news/house-inquiry-probes-whether-pbms-targeted-pharmacies-with-audits-after-reform-push</loc><news:news><news:publication><news:name>PharmaWire.org</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T08:08:38.000Z</news:publication_date><news:title>House inquiry probes whether PBMs targeted pharmacies with audits after reform push</news:title></news:news></url>
<url><loc>https://www.pharmawire.org/latest-news/astrazeneca-made-10bn-offer-for-obesity-drugmaker-rhythm-sources-say</loc><news:news><news:publication><news:name>PharmaWire.org</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T07:00:00.000Z</news:publication_date><news:title>AstraZeneca made $10bn offer for obesity drugmaker Rhythm, sources say</news:title></news:news></url>
<url><loc>https://www.pharmawire.org/latest-news/albertsons-ordered-to-pay-900mn-for-fueling-washington-state-opioid-epidemic</loc><news:news><news:publication><news:name>PharmaWire.org</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T06:53:00.000Z</news:publication_date><news:title>Albertsons ordered to pay $900mn for fueling Washington state opioid epidemic</news:title></news:news></url>
</urlset>